Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor TherapyVOSS, Martin H; HAKIMI, A. Ari; SOCCI, Nicholas D et al.Clinical cancer research (Print). 2014, Vol 20, Num 7, pp 1955-1964, issn 1078-0432, 10 p.Article

A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor GrowthCHEN, David Y; LEE, Yishan; OH, Kyoung J et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 3, pp 736-746, issn 0008-5472, 11 p.Article

Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell CarcinomaARI HAKIMI, A; CHEN, Ying-Bei; VOSS, Martin H et al.European urology. 2013, Vol 63, Num 5, pp 848-854, issn 0302-2838, 7 p.Article

Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpointHAN LIU; TAKEDA, Shugaku; KUMAR, Rakesh et al.Nature (London). 2010, Vol 467, Num 7313, pp 343-346, issn 0028-0836, 4 p.Article